Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study
ABSTRACT Purpose To describe the prescription of antibiotics before, during and after pregnancy, and the trends over a 16‐year period in the Netherlands, and to determine whether they were prescribed according to national guidelines. Methods The IADB (http://iadb.nl) contains prescriptions dispensed...
Gespeichert in:
Veröffentlicht in: | Pharmacoepidemiology and drug safety 2014-01, Vol.23 (1), p.60-68 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 68 |
---|---|
container_issue | 1 |
container_start_page | 60 |
container_title | Pharmacoepidemiology and drug safety |
container_volume | 23 |
creator | de Jonge, Linda Bos, H. Jens van Langen, Irene M. de Jong-van den Berg, Lolkje T. W. Bakker, Marian K. |
description | ABSTRACT
Purpose
To describe the prescription of antibiotics before, during and after pregnancy, and the trends over a 16‐year period in the Netherlands, and to determine whether they were prescribed according to national guidelines.
Methods
The IADB (http://iadb.nl) contains prescriptions dispensed by community pharmacies in the Netherlands. We extracted information on 18 873 pregnancies for 14 969 women between 1994 and 2009, focusing on antibiotics dispensed in the four trimesters before conception to two trimesters after birth (nine trimesters in total). We calculated trends in prescription rates during pregnancy and over time, and also compared the prescription of antibiotics in the Netherlands with safety category based on the Australian Drug Evaluation Committee.
Results
During pregnancy 20.8% of the women were prescribed at least one antibiotic. The ‘beta‐lactam antibacterials/penicillins’ group and the specific antibiotic amoxicillin were most commonly prescribed in the nine trimesters covered. The prescription rate of the ‘other antibacterials’ group during pregnancy increased over the years, in contrast to that of the ‘sulphonamides/trimethoprim’ group, which decreased. In total, 2.0% of pregnancies were exposed to a ‘potentially harmful’ antibiotic and 0.8% to a ‘harmful’ antibiotic. Compared with the period before conception, ‘safe’ antibiotics were prescribed more often during pregnancy than the other groups.
Conclusions
One in five women was prescribed at least one antibiotic during pregnancy in the Netherlands, which is comparable with rates in other European countries. Our results suggest that antibiotics appear to be prescribed to pregnant women generally in accordance with national recommendations. Copyright © 2013 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/pds.3492 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1492643847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1490707470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5162-99b581438c864dac28838df291a7e0a2276d23211ce8806988e3f76b8d0a55563</originalsourceid><addsrcrecordid>eNqN0VtrFDEUB_BBFHtR8BNIQAQfOjWXya1vtTcrpSpV-hgyyZk1dXZmTTLo-unN0mkLguBLEsiPc5Lzr6oXBO8TjOnblU_7rNH0UbVNsNY14Vw-3pw5qxUXeqvaSekG43Knm6fVFmWaMMGb7ao7HHJow5iDS2gVIbkYWvCohW6MsIf8FMOwQHbwyHYZ4sYsBju4NQoDyt8AXUJZY19EOkAW-Tgt0JRDH37bHMYBpTz59bPqSWf7BM_nfbf6enry5eh9ffHx7Pzo8KJ2nAhaa91yRRqmnBKNt44qxZTvqCZWAraUSuEpo4Q4UAoLrRSwTopWeWw554LtVm9u667i-GOClM0yJAd9eR6MUzKkDEmU-o38H4ollo3Ehb76i96MUxzKR4qSTEjZUP1Q0MUxpQidWcWwtHFtCDabmEyJyWxiKvTlXHBql-Dv4V0uBbyegU3O9l0sEw_pwSlGmBKkuPrW_Qw9rP_Z0Hw6vpobzz6kDL_uvY3fjZBMcnN9eWbkFXt3-vmDMtfsDyZgteI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1473677429</pqid></control><display><type>article</type><title>Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>de Jonge, Linda ; Bos, H. Jens ; van Langen, Irene M. ; de Jong-van den Berg, Lolkje T. W. ; Bakker, Marian K.</creator><creatorcontrib>de Jonge, Linda ; Bos, H. Jens ; van Langen, Irene M. ; de Jong-van den Berg, Lolkje T. W. ; Bakker, Marian K.</creatorcontrib><description>ABSTRACT
Purpose
To describe the prescription of antibiotics before, during and after pregnancy, and the trends over a 16‐year period in the Netherlands, and to determine whether they were prescribed according to national guidelines.
Methods
The IADB (http://iadb.nl) contains prescriptions dispensed by community pharmacies in the Netherlands. We extracted information on 18 873 pregnancies for 14 969 women between 1994 and 2009, focusing on antibiotics dispensed in the four trimesters before conception to two trimesters after birth (nine trimesters in total). We calculated trends in prescription rates during pregnancy and over time, and also compared the prescription of antibiotics in the Netherlands with safety category based on the Australian Drug Evaluation Committee.
Results
During pregnancy 20.8% of the women were prescribed at least one antibiotic. The ‘beta‐lactam antibacterials/penicillins’ group and the specific antibiotic amoxicillin were most commonly prescribed in the nine trimesters covered. The prescription rate of the ‘other antibacterials’ group during pregnancy increased over the years, in contrast to that of the ‘sulphonamides/trimethoprim’ group, which decreased. In total, 2.0% of pregnancies were exposed to a ‘potentially harmful’ antibiotic and 0.8% to a ‘harmful’ antibiotic. Compared with the period before conception, ‘safe’ antibiotics were prescribed more often during pregnancy than the other groups.
Conclusions
One in five women was prescribed at least one antibiotic during pregnancy in the Netherlands, which is comparable with rates in other European countries. Our results suggest that antibiotics appear to be prescribed to pregnant women generally in accordance with national recommendations. Copyright © 2013 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.3492</identifier><identifier>PMID: 23913654</identifier><identifier>CODEN: PDSAEA</identifier><language>eng</language><publisher>Chichester: Blackwell Publishing Ltd</publisher><subject>amoxicillin ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; antibacterials ; Antibiotics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Clinical trial. Drug monitoring ; Cohort Studies ; community pharmacy ; Drug Prescriptions ; Drug therapy ; Drug Utilization - trends ; Female ; General pharmacology ; Humans ; Medical sciences ; Netherlands - epidemiology ; pharmacoepidemiology ; Pharmacology. Drug treatments ; Population Surveillance - methods ; Postnatal Care - methods ; Postnatal Care - trends ; Pregnancy ; Pregnancy - drug effects ; Prenatal Care - methods ; Prenatal Care - trends ; prescriptions ; safety</subject><ispartof>Pharmacoepidemiology and drug safety, 2014-01, Vol.23 (1), p.60-68</ispartof><rights>Copyright © 2013 John Wiley & Sons, Ltd.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5162-99b581438c864dac28838df291a7e0a2276d23211ce8806988e3f76b8d0a55563</citedby><cites>FETCH-LOGICAL-c5162-99b581438c864dac28838df291a7e0a2276d23211ce8806988e3f76b8d0a55563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpds.3492$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpds.3492$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28313861$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23913654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Jonge, Linda</creatorcontrib><creatorcontrib>Bos, H. Jens</creatorcontrib><creatorcontrib>van Langen, Irene M.</creatorcontrib><creatorcontrib>de Jong-van den Berg, Lolkje T. W.</creatorcontrib><creatorcontrib>Bakker, Marian K.</creatorcontrib><title>Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study</title><title>Pharmacoepidemiology and drug safety</title><addtitle>Pharmacoepidemiol Drug Saf</addtitle><description>ABSTRACT
Purpose
To describe the prescription of antibiotics before, during and after pregnancy, and the trends over a 16‐year period in the Netherlands, and to determine whether they were prescribed according to national guidelines.
Methods
The IADB (http://iadb.nl) contains prescriptions dispensed by community pharmacies in the Netherlands. We extracted information on 18 873 pregnancies for 14 969 women between 1994 and 2009, focusing on antibiotics dispensed in the four trimesters before conception to two trimesters after birth (nine trimesters in total). We calculated trends in prescription rates during pregnancy and over time, and also compared the prescription of antibiotics in the Netherlands with safety category based on the Australian Drug Evaluation Committee.
Results
During pregnancy 20.8% of the women were prescribed at least one antibiotic. The ‘beta‐lactam antibacterials/penicillins’ group and the specific antibiotic amoxicillin were most commonly prescribed in the nine trimesters covered. The prescription rate of the ‘other antibacterials’ group during pregnancy increased over the years, in contrast to that of the ‘sulphonamides/trimethoprim’ group, which decreased. In total, 2.0% of pregnancies were exposed to a ‘potentially harmful’ antibiotic and 0.8% to a ‘harmful’ antibiotic. Compared with the period before conception, ‘safe’ antibiotics were prescribed more often during pregnancy than the other groups.
Conclusions
One in five women was prescribed at least one antibiotic during pregnancy in the Netherlands, which is comparable with rates in other European countries. Our results suggest that antibiotics appear to be prescribed to pregnant women generally in accordance with national recommendations. Copyright © 2013 John Wiley & Sons, Ltd.</description><subject>amoxicillin</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>antibacterials</subject><subject>Antibiotics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Clinical trial. Drug monitoring</subject><subject>Cohort Studies</subject><subject>community pharmacy</subject><subject>Drug Prescriptions</subject><subject>Drug therapy</subject><subject>Drug Utilization - trends</subject><subject>Female</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Netherlands - epidemiology</subject><subject>pharmacoepidemiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Population Surveillance - methods</subject><subject>Postnatal Care - methods</subject><subject>Postnatal Care - trends</subject><subject>Pregnancy</subject><subject>Pregnancy - drug effects</subject><subject>Prenatal Care - methods</subject><subject>Prenatal Care - trends</subject><subject>prescriptions</subject><subject>safety</subject><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0VtrFDEUB_BBFHtR8BNIQAQfOjWXya1vtTcrpSpV-hgyyZk1dXZmTTLo-unN0mkLguBLEsiPc5Lzr6oXBO8TjOnblU_7rNH0UbVNsNY14Vw-3pw5qxUXeqvaSekG43Knm6fVFmWaMMGb7ao7HHJow5iDS2gVIbkYWvCohW6MsIf8FMOwQHbwyHYZ4sYsBju4NQoDyt8AXUJZY19EOkAW-Tgt0JRDH37bHMYBpTz59bPqSWf7BM_nfbf6enry5eh9ffHx7Pzo8KJ2nAhaa91yRRqmnBKNt44qxZTvqCZWAraUSuEpo4Q4UAoLrRSwTopWeWw554LtVm9u667i-GOClM0yJAd9eR6MUzKkDEmU-o38H4ollo3Ehb76i96MUxzKR4qSTEjZUP1Q0MUxpQidWcWwtHFtCDabmEyJyWxiKvTlXHBql-Dv4V0uBbyegU3O9l0sEw_pwSlGmBKkuPrW_Qw9rP_Z0Hw6vpobzz6kDL_uvY3fjZBMcnN9eWbkFXt3-vmDMtfsDyZgteI</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>de Jonge, Linda</creator><creator>Bos, H. Jens</creator><creator>van Langen, Irene M.</creator><creator>de Jong-van den Berg, Lolkje T. W.</creator><creator>Bakker, Marian K.</creator><general>Blackwell Publishing Ltd</general><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>201401</creationdate><title>Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study</title><author>de Jonge, Linda ; Bos, H. Jens ; van Langen, Irene M. ; de Jong-van den Berg, Lolkje T. W. ; Bakker, Marian K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5162-99b581438c864dac28838df291a7e0a2276d23211ce8806988e3f76b8d0a55563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>amoxicillin</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>antibacterials</topic><topic>Antibiotics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Clinical trial. Drug monitoring</topic><topic>Cohort Studies</topic><topic>community pharmacy</topic><topic>Drug Prescriptions</topic><topic>Drug therapy</topic><topic>Drug Utilization - trends</topic><topic>Female</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Netherlands - epidemiology</topic><topic>pharmacoepidemiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Population Surveillance - methods</topic><topic>Postnatal Care - methods</topic><topic>Postnatal Care - trends</topic><topic>Pregnancy</topic><topic>Pregnancy - drug effects</topic><topic>Prenatal Care - methods</topic><topic>Prenatal Care - trends</topic><topic>prescriptions</topic><topic>safety</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Jonge, Linda</creatorcontrib><creatorcontrib>Bos, H. Jens</creatorcontrib><creatorcontrib>van Langen, Irene M.</creatorcontrib><creatorcontrib>de Jong-van den Berg, Lolkje T. W.</creatorcontrib><creatorcontrib>Bakker, Marian K.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Jonge, Linda</au><au>Bos, H. Jens</au><au>van Langen, Irene M.</au><au>de Jong-van den Berg, Lolkje T. W.</au><au>Bakker, Marian K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><addtitle>Pharmacoepidemiol Drug Saf</addtitle><date>2014-01</date><risdate>2014</risdate><volume>23</volume><issue>1</issue><spage>60</spage><epage>68</epage><pages>60-68</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><coden>PDSAEA</coden><abstract>ABSTRACT
Purpose
To describe the prescription of antibiotics before, during and after pregnancy, and the trends over a 16‐year period in the Netherlands, and to determine whether they were prescribed according to national guidelines.
Methods
The IADB (http://iadb.nl) contains prescriptions dispensed by community pharmacies in the Netherlands. We extracted information on 18 873 pregnancies for 14 969 women between 1994 and 2009, focusing on antibiotics dispensed in the four trimesters before conception to two trimesters after birth (nine trimesters in total). We calculated trends in prescription rates during pregnancy and over time, and also compared the prescription of antibiotics in the Netherlands with safety category based on the Australian Drug Evaluation Committee.
Results
During pregnancy 20.8% of the women were prescribed at least one antibiotic. The ‘beta‐lactam antibacterials/penicillins’ group and the specific antibiotic amoxicillin were most commonly prescribed in the nine trimesters covered. The prescription rate of the ‘other antibacterials’ group during pregnancy increased over the years, in contrast to that of the ‘sulphonamides/trimethoprim’ group, which decreased. In total, 2.0% of pregnancies were exposed to a ‘potentially harmful’ antibiotic and 0.8% to a ‘harmful’ antibiotic. Compared with the period before conception, ‘safe’ antibiotics were prescribed more often during pregnancy than the other groups.
Conclusions
One in five women was prescribed at least one antibiotic during pregnancy in the Netherlands, which is comparable with rates in other European countries. Our results suggest that antibiotics appear to be prescribed to pregnant women generally in accordance with national recommendations. Copyright © 2013 John Wiley & Sons, Ltd.</abstract><cop>Chichester</cop><pub>Blackwell Publishing Ltd</pub><pmid>23913654</pmid><doi>10.1002/pds.3492</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1053-8569 |
ispartof | Pharmacoepidemiology and drug safety, 2014-01, Vol.23 (1), p.60-68 |
issn | 1053-8569 1099-1557 |
language | eng |
recordid | cdi_proquest_miscellaneous_1492643847 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | amoxicillin Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterial agents antibacterials Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Clinical trial. Drug monitoring Cohort Studies community pharmacy Drug Prescriptions Drug therapy Drug Utilization - trends Female General pharmacology Humans Medical sciences Netherlands - epidemiology pharmacoepidemiology Pharmacology. Drug treatments Population Surveillance - methods Postnatal Care - methods Postnatal Care - trends Pregnancy Pregnancy - drug effects Prenatal Care - methods Prenatal Care - trends prescriptions safety |
title | Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A06%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotics%20prescribed%20before,%20during%20and%20after%20pregnancy%20in%20the%20Netherlands:%20a%20drug%20utilization%20study&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=de%20Jonge,%20Linda&rft.date=2014-01&rft.volume=23&rft.issue=1&rft.spage=60&rft.epage=68&rft.pages=60-68&rft.issn=1053-8569&rft.eissn=1099-1557&rft.coden=PDSAEA&rft_id=info:doi/10.1002/pds.3492&rft_dat=%3Cproquest_cross%3E1490707470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1473677429&rft_id=info:pmid/23913654&rfr_iscdi=true |